[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608855":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":36,"centralContacts":40,"locations":49,"responsibleParty":68,"collaborators":29,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":29,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":29,"studyType":83,"phases":84,"briefSummary":74,"conditions":86,"keywords":29,"overallStatus":88,"whyStopped":29,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Radicle Science","INDUSTRY",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Active Product 1","EXPERIMENTAL","Hydration Active Product 1",[13],"Dietary Supplement: Hydration Active Product 1",{"label":15,"type":10,"description":16,"interventionNames":17},"Active Product 2","Hydration Active Product 2",[18],"Dietary Supplement: Hydration Active Product 2",{"label":20,"type":10,"description":21,"interventionNames":22},"Active Product 3","Hydration Active Product 3",[23],"Dietary Supplement: Hydration Active Product 3",[25,30,33],{"type":26,"name":11,"description":27,"armGroupLabels":28,"otherNames":29},"DIETARY_SUPPLEMENT","Participants will use their Hydration Active Product 1 as directed for a period of 1 week.",[9],null,{"type":26,"name":16,"description":31,"armGroupLabels":32,"otherNames":29},"Participants will use their Hydration Active Product 2 as directed for a period of 1 week.",[15],{"type":26,"name":21,"description":34,"armGroupLabels":35,"otherNames":29},"Participants will use their Hydration Active Product 3 as directed for a period of 1 week.",[20],[37],{"name":38,"affiliation":5,"role":39},"Susan Hewlings","PRINCIPAL_INVESTIGATOR",[41,46],{"name":42,"role":43,"phone":44,"phoneExt":29,"email":45},"Study Manager","CONTACT","858-779-0086","studymgmt@radiclescience.com",{"name":38,"role":43,"phone":47,"phoneExt":29,"email":48},"760-281-3898","susan.hewlings@radiclescience.com",[50],{"facility":51,"status":29,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"Radicle Science Inc.","Del Mar","California","92014","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-117.26531,32.95949,{"lat":61,"lon":60},[64,65],{"name":42,"role":43,"phone":47,"phoneExt":29,"email":45},{"name":66,"role":43,"phone":29,"phoneExt":29,"email":67},"Megan Mosely","megan@radiclescience.com",{"type":69,"investigatorFullName":29,"investigatorTitle":29,"investigatorAffiliation":29,"oldNameTitle":29,"oldOrganization":29},"SPONSOR","100608855","an-open-label-trial-assessing-the-impact-of-a-hydration-formula-on-overall-health-100608855",false,"NCT07206979","An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health","3.1 Inclusion\n\nParticipants must meet all the following criteria:\n\n* Adults, at least 21 years of age at the time of electronic consent, inclusive of all ethnicities, races.\n* Resides in the United States.\n\n3.2 Exclusion\n\nIndividuals who report any of the following during screening will be excluded from participation:\n\n* Report being pregnant, trying to become pregnant, or breastfeeding.\n* Unable to provide a valid US shipping address and mobile phone number\n* Unable to read and understand English.\n* Reports a current and\u002For recent (up to 3 months ago) major illness and\u002For surgery that poses a known, significant safety risk.\n* Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and\u002For a significant safety risk with any of the study product ingredients.\n\n  * NYHA Class III or IV congestive heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure.\n* Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study product ingredients.\n\n  * Anticoagulants, antihypertensives, anxiolytics, antidepressants, chemotherapy, immunotherapy, sedative hypnotics, seizure medications, medications that warn against grapefruit consumption, corticosteroids at doses greater than 5 mg per day, diabetic medications, oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection, antipsychotics, MAOIs, or thyroid products.\n* Reports the current use of electrolyte and\u002For hydration supplements that may limit the effects of the study products.\n* Lack of reliable daily access to the internet.",true,"ALL","21 Years","105 Years",{"count":81,"type":82},660,"ESTIMATED","INTERVENTIONAL",[85],"NA",[87],"Hydration","NOT_YET_RECRUITING","2025-09-26",{"date":91,"type":92},"2025-10-03","ACTUAL",{"date":94,"type":82},"2025-09-30",{"date":96,"type":82},"2026-09-30",{"name":5,"class":6},1]